Investment Management Mercken SRL
Investment Management Mercken reported total assets of 119,761 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Mar 2026).
The score of Investment Management Mercken shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +102 % Total assets +101 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Investment Management Mercken's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Mar 2026
- Year ended 31 Dec 2024filed on 26 Mar 2025
- Year ended 31 Dec 2023filed on 15 Mar 2024
Investment Management Mercken's financial analysis
- Solvency86.7%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Investment Management Mercken
Investment Management Mercken's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0784.436.327
- VAT number
- BE0784436327
- Peppol
- Registered · 0208:0784436327 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Apr 2022
- Registered office
- 2500 Lier
- Latest accounts
- 2025 · filed on 17 Mar 2026
- Activity
- Activities of holding companies (NACE 64210)
Investment Management Mercken (SRL) has been based in Lier since 2022, active in: activities of holding companies. For 2025, it reports a net profit of 23,819 € and equity of 103,885 €; its revenue is not published. Its solvency stands at 86.7%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Investment Management Mercken
Companies in the same business, of comparable size and area, outside its group.
- Y-magic Activities of holding companies Zonhoven · balance sheet 118,230 €
- Vromex Activities of holding companies Izegem · balance sheet 125,363 €
- van PUIJENBROEK MANAGEMENT Activities of holding companies Beersel · balance sheet 179,001 €
- WB Beheer Activities of holding companies Antwerp · balance sheet 11,510 €
- I.M.C. Smeets Activities of holding companies Antwerp · balance sheet 393,914 €
- Optimakon Activities of holding companies Zoersel · balance sheet 113,886 €
- Textielbaron Activities of holding companies Nazareth-De Pinte · balance sheet 111,465 €
- Cathect Activities of holding companies Kampenhout · balance sheet 115,027 €
Frequently asked questions about Investment Management Mercken
What is the revenue of Investment Management Mercken?
Investment Management Mercken files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Investment Management Mercken?
In Belgium, the VAT number is the company number prefixed with BE: BE0784436327 for Investment Management Mercken, if the company is VAT-registered. Its company number (CBE) is 0784.436.327.
Where is the registered office of Investment Management Mercken?
According to the CBE register, the registered office of Investment Management Mercken is in 2500 Lier.
What is the equity of Investment Management Mercken?
At the close of the 2025 financial year, the equity of Investment Management Mercken amounts to 103,885 €, a solvency of 86.7% of total assets.
Who manages Investment Management Mercken?
The register lists 1 active mandates at Investment Management Mercken. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Investment Management Mercken
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →